hydrocortisone acetate pramoxine HCl NDC 71335-2934

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2934Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2934Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71335-2934-1	71335293401	1 TUBE in 1 CARTON (71335-2934-1) / 57 g in 1 TUBEMarketed from Oct 24, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): hydrocortisone acetate pramoxine HCl
Generic name (nonproprietary): hydrocortisone acetate, pramoxine hcl
Active ingredients: Hydrocortisone acetate — 2.5 g/100gPramoxine hydrochloride — 1 g/100g
Dosage form: Cream
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Mar 29, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 71335-2934_5f2dc77f-8ad5-476d-ac18-b384e594dbc3SPL ID 5f2dc77f-8ad5-476d-ac18-b384e594dbc3SPL set ID d59665d7-a0f4-4318-b452-171c54ed156cRxCUI 1234506UNII 3X7931PO74, 88AYB867L5
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335293401 followed by a unit qualifier and the quantity

Package 71335-2934-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 24, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)